维普中文期刊产品整合服务
8篇 您的检索式:作者名="Stochaj"
    题名 作者 年代 出处 被引量
1Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression显示文摘Kizilay Mancini O Shum-Tim D Stochaj U 2015Stem Cell Research & Therapy2015,6,1:1
2Bleaching in coral reef anthozoans: effects of irradiance, ultraviolet radiation, and temperature on the activities of protective enzymes against active oxygen 显示文摘LESSER M P STOCHAJ W R TAPLEY D W 1990Coral Reefs1990,8,4:1
3Age,atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression显示文摘Kizilay MO Shum-Tim D Stochaj U 2015Stem Cell Res Ther2015,6,3:1
4Bleaching in coral-reef anthozoans-effects of irradiance, ultraviolet-radiation, and temperature on the activities of protective enzymens against active oxygen 显示文摘LESSER M STOCHAJ W R TAPLEY D W 1990Coral Reefs1990,8,4:1
5Bleaching in coral reef anthozoans:effects of irradiance,ultraviolet radiation,and temperature on the activities of protective enzymes against active oxygen显示文摘Lesser M P Stochaj W R Tapley D W 0,,04:1
6Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression 显示文摘Kizilay Maneini O Shum-Tim D Stochaj U 2015Stem Cell Res Ther2015,6,:1
7Bleaching in coral reef Anthozoans:effects of irradiance,ultraviolet radiation and temperature,on the activities ofprotective enzymes against active oxygen显示文摘LESSER M P STOCHAJ W R TAPLEY D W 1990Coral reefs1990,8,:1
8Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance显示文摘One of the major obstacles of successful cancer therapy is cancer drug resistance.The unique tools and applications developed by nanomedicine provide new approaches to surmount this common limitation of current treatment regimens.Nanocarriers that absorb light in the near-infrared spectrum are particularly suitable for this purpose.These nanocarriers can produce heat,release drugs or stimulate the production of physiologically relevant compounds when illuminated with near-infrared light.The current review summarizes the causes contributing to cancer multidrug resistance.The major types of nanocarriers that have been developed in recent years to overcome these hurdles are described.We focus on nanoparticles that are responsive to near-infrared light and suitable to surmount cancer multidrug resistance.Our review concludes with the bottlenecks that currently restrict the use of nanocarriers in the clinic and an outlook on future directions.Siwei Chu Ursula Stochaj 2020Cancer Drug Resistance2020,3,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费